Publish in this journal
Journal Information
Vol. 61. Issue 3.
Pages 328 (March 2008)
Response
DOI: 10.1016/S1885-5857(08)60124-3
Full text access
Response
Respuesta
Visits
...
José A Rodrígueza, Josune Orbea, José A Páramoa
a Laboratorio de Aterosclerosis, Área de Ciencias Cardiovasculares, CIMA-Universidad de Navarra, Pamplona, Navarra, Spain
This item has received
...
Visits
(Daily data update)
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

To the Editor:

We would like to thank Domínguez-Rodríguez et al for their interest in our article,1 in which we point to metalloproteinases (MMP) 9 and 10 as promising biomarkers of cardiovascular risk. In their letter, these authors make an important observation by highlighting the relevance of circadian variations in circulating MMP-9 concentrations, based on their previous data showing diurnal variations in MMP-9 serum concentration in patients with acute coronary syndrome2 not observed in healthy volunteers.3 The information provided reinforces our opinion on the adequate validation of new candidates for biomarkers, and the need to demonstrate reliability, stability, low variability, and standardization of such markers in the methodology used to measure them.1,4

Furthermore, the information provided by Domínguez-Rodríguez et al has led us to consider the possibility that circadian variations may affect circulating MMP-10 concentrations, a question we are currently investigating.

Bibliography
[1]
Rodríguez JA, Orbe J, Páramo JA..
Metaloproteinasas, remodelado vascular y síndromes aterotrombóticos..
Rev Esp Cardiol, 60 (2007), pp. 959-67
[2]
Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Reiter RJ..
Relation of nocturnal melatonin levels to serum matrix metalloproteinase-9 concentrations in patients with myocardial infarction..
Thromb Res, 120 (2007), pp. 361-6
[3]
Tayebjee MH, Lip GY, Blann AD, Macfadyen RJ..
Effects of age, gender, ethnicity, diurnal variation and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2..
Thromb Res, 115 (2005), pp. 205-10
[4]
Páramo JA, Rodríguez JA, Orbe J..
Vulnerable plaque versus vulnerable patient: emerging blood biomarkers for risk stratification..
Endocr Metab Immune Disord Drug Targets, 7 (2007), pp. 195-201
Idiomas
Revista Española de Cardiología (English Edition)

Subscribe to our newsletter

Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?